Browsing Modes for Business Users

Yellow Fever Virus

ISO 9001 Quality Assurance Manufacturing | Print
No associated image currently available
No associated image currently available

Recombinant Yellow Fever Virus NS1 Protein

Product Type
Recombinant Protein
Specificity
Yellow Fever Virus

Quick Links:

 Antibody Quality and Performance Guarantee
 Unrivaled Technical Support
Product Code Applications Pack Size List Price Your Price Qty
PIP052A
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
E 100 µg loader
List Price Your Price
loader

Recombinant yellow fever virus NS1 protein is produced as a hexamer in the human 293 cell line. This product has been purified and retains its native folding state and post-translational modifications providing optimal antigenicity. Research indicates that the hexamer is the biologically active form of the NS1 antigen and therefore involved in the pathogenesis of yellow fever virus (YFV).

Yellow fever virus belongs to the Flaviviridae family and like closely related viruses, such as West Nile virus, is an abovirus utilizing various mosquito species as vectors. YFV appears to be restricted naturally to human and other primates but can be experimentally induced in other mammalian species. In recent years an increasing number cases of YFV infection have been reported.

Originating in Africa, YFV has been introduced to tropical regions of South America and periodic outbreaks have historically occurred in both Europe and North America. According to the World Health Organization (WHO), it has been estimated that approximately 200,000 people contract YFV annually with around 30,000 cases resulting in fatality, the majority of these on the African continent.

This product may be used in research to investigate vaccine development (Bonaldo, M.C. et al. 2014) or in research into the development of assays to detect YFV infection (Ding, X.X,et al. 2014).

Target Species
Viral
Product Form
Purified recombinant protein - liquid
Preparation
Recombinant yellow fever virus NS1 protein, sequence strain 17D, expressed in 293 human cells
Source
HEK-293
Buffer Solution
Dulbecco's phosphate buffered saline
Preservative Stabilisers
None present
Purity
>95% by SDS PAGE analysis
Approx. Protein Concentrations
Current, batch-specific concentration 0.98 mg/ml
Regulatory
For research purposes only
Guarantee
12 months from date of despatch

Store at -70oC.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein. Should this product contain a precipitate we recommend microcentrifugation before use.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.

Further Reading

  1. Ding, X.X. et al. (2014) Development of a Double Antibody Sandwich ELISA for West Nile Virus Detection Using Monoclonal Antibodies against Non-Structural Protein 1.
    PLoS One 9(10): e108623.
  2. Bonaldo, M.C. et al. (2014) The yellow fever 17D virus as a platform for new live attenuated vaccines.
    Hum Vaccin Immunother. 10(5): 1256-65.

Synonyms
YFV

PIP052A

148684 168144 170720

If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.

View more products with YELLOW FEVER VIRUS specificity

Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"

View all Anti-Viral Products
Please note